Overview

Impact of Intraoperative Deep Neuromuscular Blockade on NOL-guided Opioid Requirement in LSC Colorectal Surgeries

Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to answer the question whether deep neuromuscular blockade has a clinically significant impact on intra and postoperative pain, opioid requirement and anesthesia related outcomes and side effects for the early phase of recovery (24hs) after colorectal laparoscopic surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Ciusss de L'Est de l'Île de Montréal
Collaborator:
Merck Canada Inc.
Treatments:
Analgesics, Opioid
Rocuronium